Last checked at 
Deltex Medical Group PLC - Chichester, England-based cardiac monitoring system maker - Reports good progress towards finalising its new, next generation monitor, including completing the necessary regulatory documentation required for its launch. Intends to launch this new product in June 2023 initially in the UK and EU markets. Will then seek regulatory approval for launch into other key global markets over the next 6-18 months. In addition, continues to maximise revenues from the current generation monitor and probes via its direct sales teams in the UK and US whilst simultaneously preparing the market for the launch of the new, next generation monitor.
Current stock price: 1.53 pence, up 2.0% in London on Wednesday
12-month change: up 39%
By Jeremy Cutler, Alliance News reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2023 Alliance News Ltd. All Rights Reserved.
